Clinical Cancer Advance of the Year Is CAR T Cells – Medscape
Medscape |
Clinical Cancer Advance of the Year Is CAR T Cells
Medscape This product "can eradicate relapsed ALL in children. This represents one of the most remarkable advances in the treatment of childhood cancer in the last decade and could dramatically change treatment paradigms for this disease," the report authors … ASCO Names CAR T-Cell Therapy as Cancer Advance of the Year CAR T-cell therapy named ASCO's 'Advance of the Year' |
